<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The introduction of low-<z:chebi fb="67" ids="50114">oestrogen</z:chebi> oral contraceptives in Sweden and the concomitant disappearance of high-dose preparations did not result in a lowering of the mortality of fertile women from <z:hpo ids='HP_0001907'>thromboembolic disease</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Morbidity due to <z:hpo ids='HP_0001907'>thromboembolism</z:hpo> seems to have fallen, and the number of thromboembolic incidents reported to the Swedish Adverse Drug Reaction Committee decreased dramatically </plain></SENT>
<SENT sid="2" pm="."><plain>The decrease was due exclusively to a reduction in venous <z:hpo ids='HP_0001907'>thromboembolic disease</z:hpo>: the frequency of arterial complications (cerebral and coronary) remained constant </plain></SENT>
</text></document>